MEGABIOTECH
Biology Platform
As an independently developed, general, intelligent and automated biology laboratory, MEGALAB is focusing on the research of cell gene editing, high-throughput drug screening, synthetic biology, etc. MEGALAB is designed to build the next generation of life sciences infrastructure, to improve the efficiency of life sciences R&D and production and enable industry integration and innovation. In order to combine the automation and biology capabilities, MEGALAB provides a high-quality, automated, informationized and intelligent biology platform called MegaBiotech, which integrates high-throughput screening platform with cell engineering and gene editing platform, stem cell and organoids platform and immunology platform.
BIOLOGY PLATFORM
High-throughput Screening Platform
High-throughput biological macromolecules screening (antibodies, etc.)
High-throughput small molecule drugs screening
Biological macromolecules orthogenesis
Discovery and transformation of novel biological components
Cell Engineering and Gene Editing Platform
High-throughput monoclonal genotype screening
Gene editing-based disease model construction
Gene therapy
Cell therapy
Stem Cell and Organoids Platform
Stem cell directional differentiation condition screening
Stem cells/organoids based disease model construction
Automated organoids culture platform
Organ-on-a-Chip
Immunology Platform
Screening of novel immune targets
Immunomodulatory drug screening
Discovery of new immune checkpoint pathways
Screening and identification of tumor neoantigens
Industry applications
